Motley Fool  May 19  Comment 
A new analyst weighed in with a favorable rating on the stock and management's new direction.
Benzinga  May 19  Comment 
Leerink initiated coverage of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) with an Outperform rating and a $5 price target. New Management As A Catalyst For Growth Leerink analyst Joseph Schwartz noted several opportunities could create a...
Benzinga  Apr 18  Comment 
Cleveland BioLabs, Inc. (NASDAQ: CBLI) shares tumbled 17.3 percent to $3.97 after surging 194.48 percent on Monday. Barracuda Networks Inc (NYSE: CUDA) shares declined 16.3 percent to $19.60. Barracuda posted upbeat earnings for its fourth...
Motley Fool  Apr 18  Comment 
Arena raises capital to fund its clinical pipeline.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki